Papcup provides an at-home HPV testing solution for cervical screening, utilizing electrochemical biosensor technology for non-invasive sample collection. This platform delivers fast, accurate molecular detection results directly to the user via an accompanying app. The service aims to make cervical screening more comfortable, accessible, and dignified by eliminating the need for traditional speculum examinations.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional cervical cancer screening methods, such as Pap smears, can be uncomfortable, invasive, and require a visit to a healthcare provider. This can deter some women from getting screened regularly, potentially leading to delayed diagnosis and treatment.
Solution
Papcup offers a self-administered cervical cancer screening test that detects cancer-causing HPV strains using a menstrual blood sample or a shallow vaginal swab. The test can be performed at home, providing a convenient and less invasive alternative to traditional smear tests. Results are available within 15 minutes, offering women a faster turnaround time and greater control over their health information. The device can be linked to medical records, allowing users to easily share results with their General Practitioner.
Target Audience
The primary target audience is women who are seeking a more comfortable, convenient, and private alternative to traditional cervical cancer screening methods.
Features
- Non-invasive sample collection using menstrual blood or a shallow vaginal swab
- Rapid results within 15 minutes
- At-home testing for increased convenience and privacy
- Detection of cancer-causing HPV strains, adhering to NHS and WHO standards
- Option to link test results to medical records for seamless sharing with healthcare providers